Dr Adrian Minson is a clinical and laboratory haematologist with a special interest in novel immunotherapies for aggressive B-cell lymphomas. He has completed a lymphoma fellowship and PhD at the Peter MacCallum Cancer Centre and Royal Melbourne Hospitals investigating how to best use T-cell re-directing immunotherapies to improve patient outcomes. Adrian is an investigator on numerous early-phase studies using CAR T-cells and bispecific antibodies, and is co-running a program of Australia- and NZ-wide investigator-initiated studies using these treatments in key high-risk patient populations.

Rachel Lou is a Year 3 Bachelor of Medical Science, Doctor of Medicine student at Monash University. She has an interest in leukaemia and lymphoma with internships at Yale School of Medicine 2024-2026 and Monash Biomedical Discovery Institute. She has been selected for Monash University’s Ancora Imparo Leadership Program.

Judith Trotman (MBChB, FRACP, FRCPA) is Lymphoma and Community Partnerships Lead, Concord Repatriation General Hospital, University of Sydney; Chair of the ALLG Scientific Advisory Committee; Founder of Women in Lymphoma and develops digital initiatives in physician-patient partnerships, including the ClinTrial Refer App, and the WhiMSICAL and MyHodgkin MyHealth Apps.

Dr. Shin Hnin Wai is a clinical and laboratory haematologist based in Melbourne. As the Lymphoma Fellow at Alfred Health, she is developing her career as a clinician-researcher.

Dr Ricky Nelles is a consultant haematologist at Royal Brisbane and Women’s Hospital with a special interest in lymphoma. After completing haematology training in Queensland he undertook lymphoma fellowships at the Princess Alexandra Hospital in Queensland and University College London Hospital in the UK before returning to Brisbane.

Nate Lucas is an Early Career Paediatric Haematologist at Starship Hospital and a PhD candidate with the Transfusion Research Unit at Monash University. His research focuses on improving the diagnostic work-up and understanding of bone marrow failure syndromes.